Current controlled trials in cardiovascular medicine
| Nuevo Título: | TRIALS |
|---|---|
| Autor Corporativo: | |
| Formato: | Revista digital |
| Idioma: | Inglés |
| Publicado: |
[London] :
BioMed Central
2000-2005.
London : [2000] |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009425500606719 |
Tabla de Contenidos:
- Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
- Comments on ALLHAT and doxazosin
- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
- Debate: PCI vs CABG: a moving target, but we are gaining
- Debate: Should statin be used in patients with heart failure?
- Debate: Statins should be used in patients with heart failure
- Cytokines as new treatment targets in chronic heart failure
- Therapeutic angiogenesis for cardiovascular disease
- Distal protection devices during percutaneous coronary and carotid interventions
- Biventricular pacing in heart failure: update on results from clinical trials
- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)
- A new era in hypertension research: discussing the findings of ALLHAT.
